Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor-Reference-Cited by-同舟云学术

Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor

Published:2008-08-15 Issue:4 Volume:58 Page:531-546
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Figini Mariangela,Martin Franck,Ferri Renata,Luison Elena,Ripamonti Elena,Zacchetti Alberto,Mortarino Mimosa,Di Cioccio Vito,Maurizi Giovanni,Allegretti Marcello,Canevari Silvana

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-008-0575-5.pdf

Reference38 articles.

1. Committee on cancer research (UKCCCR), United Kingdom (1998) Guidelines for the welfare of animals in experimental neoplasia, 2nd edn. Br J Cancer 77: 1–10

2. Adamczyk M, Gebler JC, Wu J, Yu Z (2002) Complete sequencing of anti-vancomycin Fab fragment by liquid chromatography-electrospray ion trap mass spectrometry with a combination of database searching and manual interpretation of the MS/MS spectra. J Immunol Methods 260:235–249

3. Alberti S, Miotti S, Fornaro M, Mantovani L, Walter S, Canevari S, Ménard S, Colnaghi MI (1990) The Ca-MOv18 molecule, a cell-surface marker of human ovarian carcinomas, is anchored to the cell membrane by phosphatidylinositol. Biochem Biophys Res Commun 171:1051–1055

4. Brack SS, Silacci M, Birchler M, Neri D (2006) Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clin Cancer Res 12:3200–3208

5. Canevari S, Pupa SM, Menard S (1996) 1975–1995 revised anti-cancer serological response: biological significance and clinical implications. Ann Oncol 7:227–232

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa;Antibody Therapeutics;2022-10-01

2. Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine;Clinical and Translational Imaging;2019-07-31

3. Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy;Cancer Immunology, Immunotherapy;2018-01-08

4. Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy;Cancer Immunology, Immunotherapy;2016-12-08

5. Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level;Journal of Hematology & Oncology;2016-07-20